Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
pilot human infusions well tolerated Learn More TB-500 Overview TB-500 Overview Mechanisms: Binds actin to enhance cytoskeletal remodeling and cell migrationcritical for tissue repair Learn More Primary Uses: Muscle tears, tendon/ligament injuries, cardiac protection Learn More Administration: Subcutaneous or intramuscular injections (not orally bioavailable) Safety Highlights: Low acute toxicity in animal models
Zofran Injections Highly effective antiemetic used for treating nausea and vomiting
If you're combining BPC-157 with other peptides, professional guidance can help ensure each one fits your goals
Rommel P
Epithalon research record Clear product, batch, storage, dispatch and document information for this 10-vial case
Like BPC-157, TB-500 is scheduled for FDA advisory committee review in July 2026
